Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
alirocumab
3
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
3
×
new york blog main
new york top stories
regeneron pharmaceuticals
amgen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
evolocumab
fda
inclisiran
indiana blog main
indiana top stories
national
pcsk9
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alex azar
alnylam pharmaceuticals
american patients first
biosimilars
cardiac
What
drug
cholesterol
drugs
new
wave
acquire
afternoon
agreed
anticipated
awaited
billion
blueprint
brings
cash
company
compound
cost
cut
deal
details
expensive
faces
fda
financial
foe
healthcare
hint
house
inhibitors
known
long
lower
lowering
meant
medco
medicines
novartis
pcsk
plan
pledges
Language
unset
Current search:
alirocumab
×
photo
×
" national top stories "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details